Anti-TGF beta monoclonal antibody for diabetes - Eli LillyAlternative Names: Anti-TGF-beta-1 monoclonal antibody for diabetes - Eli Lilly
Latest Information Update: 05 Aug 2015
At a glance
- Originator Eli Lilly
- Class Monoclonal antibodies; Neuroprotectants
- Mechanism of Action Immunomodulators
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Diabetes mellitus
Most Recent Events
- 31 Dec 2010 Phase-II clinical trials in Diabetes mellitus in USA (SC)